Cargando…

A Facile Platform to Engineer Escherichia coli Tyrosyl-tRNA Synthetase Adds New Chemistries to the Eukaryotic Genetic Code, Including a Phosphotyrosine Mimic

[Image: see text] The Escherichia coli tyrosyl-tRNA synthetase (EcTyrRS)/tRNA(EcTyr) pair offers an attractive platform for genetically encoding new noncanonical amino acids (ncAA) in eukaryotes. However, challenges associated with a eukaryotic selection system, which is needed to engineer the platf...

Descripción completa

Detalles Bibliográficos
Autores principales: Grasso, Katherine T., Singha Roy, Soumya Jyoti, Osgood, Arianna O., Yeo, Megan Jin Rae, Soni, Chintan, Hillenbrand, Christen M., Ficaretta, Elise D., Chatterjee, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088295/
https://www.ncbi.nlm.nih.gov/pubmed/35559426
http://dx.doi.org/10.1021/acscentsci.1c01465
Descripción
Sumario:[Image: see text] The Escherichia coli tyrosyl-tRNA synthetase (EcTyrRS)/tRNA(EcTyr) pair offers an attractive platform for genetically encoding new noncanonical amino acids (ncAA) in eukaryotes. However, challenges associated with a eukaryotic selection system, which is needed to engineer the platform, have impeded its success in the past. Recently, using a facile E. coli-based selection system, we showed that EcTyrRS could be engineered in a strain where the endogenous tyrosyl pair was substituted with an archaeal counterpart. However, significant cross-reactivity between the UAG-suppressing tRNA(CUA)(EcTyr) and the bacterial glutaminyl-tRNA synthetase limited the scope of this strategy, preventing the selection of moderately active EcTyrRS mutants. Here we report an engineered tRNA(CUA)(EcTyr) that overcomes this cross-reactivity. Optimized selection systems based on this tRNA enabled the efficient enrichment of both strongly and weakly active ncAA-selective EcTyrRS mutants. We also developed a wide dynamic range (WiDR) antibiotic selection to further enhance the activities of the weaker first-generation EcTyrRS mutants. We demonstrated the utility of our platform by developing several new EcTyrRS mutants that efficiently incorporated useful ncAAs in mammalian cells, including photoaffinity probes, bioconjugation handles, and a nonhydrolyzable mimic of phosphotyrosine.